Background Lung cancer treatment decisions are typically made among clinical experts in a
multidisciplinary tumour board (MTB) based on clinical data and guidelines. The rise of …

Background Decision-making in lung cancer is complex due to a rapidly increasing amount
of diagnostic data and treatment options. The need for timely and accurate diagnosis and …

Introduction The value of shared decision-making and decision aids (DA) has been well
documented yet remain difficult to integrate into clinical practice. We wanted to investigate …

Abstract Treatment decision-making for patients with incurable non-small cell lung cancer
(NSCLC) is complex due to the rapidly increasing number of treatments and discovery of …

Background: Treatment options for lung cancer patients are progressing rapidly. A clinical
decision support system (CDSS) which affords first-line treatment recommendations for …

Background Shared decision-making (SDM), which increases the patient's well-being,
adherence, and success of treatment, is becoming increasingly important in medicine and …

Few treatment decision support interventions (DSIs) are available to engage patients
diagnosed with late-stage non-small cell lung cancer (NSCLC) in treatment shared decision …

Objective A patient decision aid (PtDA) is often developed and evaluated to support shared
decision making (SDM) and a patient‐centred approach. In this study, a PtDA template was …

Background Despite an increased awareness of shared decision-making (SDM) and its
prominent position on the health policy agenda, its implementation in routine care remains a …

OBJECTIVES To investigate the opinions of lung cancer clinicians concerning shared
decision making (SDM) in early-stage non-small-cell lung cancer patients. METHODS A …